Agenda:
|
|
Chairperson: Dr. Kunihiro Yamaoka
|
|
TBA mins |
Welcome Remarks: Introduction
|
|
TBA mins |
Frontiers in targeted therapy on RANKL: Bone protection strategy for rheumatic diseases by denosumab
Prof Tsutomu Takeuchi (竹内勤) |
|
TBA mins |
Closing Remarks: Q&A and Discussion
All |
